Proton Collaborative Group

Quick facts

Phase 3 pipeline

• Androgen Suppression Therapy · Oncology
  Androgen suppression therapy reduces circulating testosterone and DHT levels to inhibit androgen-dependent cancer cell growth.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Proton Collaborative Group portfolio CI brief
• Proton Collaborative Group pipeline updates RSS